Latest Insider Transactions at Avantor, Inc. (AVTR)
This section provides a real-time view of insider transactions for Avantor, Inc. (AVTR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Avantor, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Avantor, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 20
2021
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Open market or private sale
|
Direct |
6,112
-7.11%
|
$226,144
$37.0 P/Share
|
|
Jul 15
2021
|
John Carethers Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,565
+50.0%
|
-
|
|
Jul 12
2021
|
Jo Natauri Director |
BUY
Open market or private purchase
|
Indirect |
300
+0.05%
|
$10,800
$36.33 P/Share
|
|
Jul 09
2021
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Open market or private sale
|
Direct |
18,331
-9.15%
|
$641,585
$35.6 P/Share
|
|
Jun 28
2021
|
Christophe Couturier EVP, AMEA |
SELL
Open market or private sale
|
Direct |
28,096
-20.33%
|
$983,360
$35.73 P/Share
|
|
Jun 25
2021
|
Rajiv Gupta Director |
SELL
Open market or private sale
|
Direct |
68,605
-4.74%
|
$2,401,175
$35.32 P/Share
|
|
Jun 10
2021
|
Michael Stubblefield President & CEO |
SELL
Open market or private sale
|
Direct |
99,887
-3.43%
|
$3,196,384
$32.48 P/Share
|
|
Jun 10
2021
|
Michael Stubblefield President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
99,887
+3.32%
|
$299,661
$3.66 P/Share
|
|
Jun 09
2021
|
Michael Stubblefield President & CEO |
SELL
Open market or private sale
|
Direct |
235,170
-14.35%
|
$7,525,440
$32.03 P/Share
|
|
Jun 09
2021
|
Michael Stubblefield President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
235,170
+12.55%
|
$705,510
$3.13 P/Share
|
|
Jun 08
2021
|
Michael Stubblefield President & CEO |
SELL
Open market or private sale
|
Direct |
152,643
-9.81%
|
$4,884,576
$32.04 P/Share
|
|
Jun 08
2021
|
Michael Stubblefield President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
152,643
+8.93%
|
$457,929
$3.13 P/Share
|
|
May 27
2021
|
Devashish Ohri EVP, IMEA |
SELL
Open market or private sale
|
Direct |
100,000
-41.82%
|
$3,100,000
$31.99 P/Share
|
|
May 27
2021
|
Devashish Ohri EVP, IMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+29.49%
|
$2,300,000
$23.21 P/Share
|
|
May 27
2021
|
Rajiv Gupta Director |
SELL
Open market or private sale
|
Indirect |
78,109
-21.93%
|
$2,421,379
$31.94 P/Share
|
|
May 26
2021
|
Rajiv Gupta Director |
SELL
Open market or private sale
|
Indirect |
150,000
-29.63%
|
$4,650,000
$31.89 P/Share
|
|
May 26
2021
|
Devashish Ohri EVP, IMEA |
SELL
Open market or private sale
|
Direct |
15,000
-9.73%
|
$465,000
$31.87 P/Share
|
|
May 26
2021
|
Devashish Ohri EVP, IMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.87%
|
$345,000
$23.21 P/Share
|
|
May 24
2021
|
Rajiv Gupta Director |
SELL
Open market or private sale
|
Indirect |
337,571
-22.54%
|
$10,464,701
$31.66 P/Share
|
|
May 24
2021
|
Devashish Ohri EVP, IMEA |
SELL
Open market or private sale
|
Direct |
9,124
-6.16%
|
$282,844
$31.75 P/Share
|
|
May 24
2021
|
Devashish Ohri EVP, IMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
9,124
+5.8%
|
$155,108
$17.67 P/Share
|
|
May 21
2021
|
Michael Wondrasch EVP & CIO |
SELL
Open market or private sale
|
Direct |
18,488
-14.03%
|
$573,128
$31.41 P/Share
|
|
May 20
2021
|
Gerard Brophy EVP, Biopharma Production |
SELL
Open market or private sale
|
Direct |
19,603
-11.6%
|
$607,693
$31.1 P/Share
|
|
May 20
2021
|
Christophe Couturier EVP, AMEA |
SELL
Open market or private sale
|
Direct |
25,010
-15.33%
|
$775,310
$31.13 P/Share
|
|
May 20
2021
|
Justin Miller EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
18,488
-17.6%
|
$573,128
$31.12 P/Share
|
|
May 17
2021
|
Devashish Ohri EVP, IMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
16,793
-10.77%
|
$503,790
$30.9 P/Share
|
|
May 17
2021
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
14,276
-8.04%
|
-
|
|
May 17
2021
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
106,200
-7.04%
|
$3,186,000
$30.9 P/Share
|
|
May 17
2021
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
553
-1.72%
|
$16,590
$30.9 P/Share
|
|
May 17
2021
|
Michael Wondrasch EVP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,655
-9.39%
|
$409,650
$30.9 P/Share
|
|
May 17
2021
|
Justin Miller EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
13,655
-11.51%
|
$409,650
$30.9 P/Share
|
|
May 17
2021
|
Thomas A Szlosek EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,261
-8.53%
|
$697,830
$30.9 P/Share
|
|
May 17
2021
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
14,324
-12.13%
|
$429,720
$30.9 P/Share
|
|
May 17
2021
|
Frederic Vanderhaegen EVP, Americas and Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
2,210
-1.02%
|
$66,300
$30.9 P/Share
|
|
May 17
2021
|
Gerard Brophy EVP, Biopharma Production |
SELL
Payment of exercise price or tax liability
|
Direct |
19,683
-10.43%
|
$590,490
$30.9 P/Share
|
|
May 14
2021
|
Lan Kang Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,022
+50.0%
|
-
|
|
May 14
2021
|
Devashish Ohri EVP, IMEA |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,000
-13.82%
|
$775,000
$31.5 P/Share
|
|
May 14
2021
|
Devashish Ohri EVP, IMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+12.14%
|
$575,000
$23.21 P/Share
|
|
May 11
2021
|
Jo Natauri Director |
BUY
Other acquisition or disposition
|
Direct |
92,661
+50.0%
|
$2,779,830
$30.86 P/Share
|
|
May 11
2021
|
Jo Natauri Director |
SELL
Other acquisition or disposition
|
Indirect |
24,729,495
-99.29%
|
$741,884,850
$30.86 P/Share
|
|
May 11
2021
|
Jo Natauri Director |
SELL
Open market or private sale
|
Indirect |
2,626,771
-9.57%
|
$78,803,130
$30.68 P/Share
|
|
Apr 30
2021
|
Devashish Ohri EVP, IMEA |
SELL
Open market or private sale
|
Direct |
53,649
-25.6%
|
$1,716,768
$32.58 P/Share
|
|
Apr 30
2021
|
Devashish Ohri EVP, IMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
53,649
+20.38%
|
$1,233,927
$23.21 P/Share
|
|
Apr 12
2021
|
Justin Miller EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
102,895
-24.06%
|
$3,292,640
$32.48 P/Share
|
|
Apr 12
2021
|
Justin Miller EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+31.38%
|
$2,300,000
$23.21 P/Share
|
|
Apr 12
2021
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Open market or private sale
|
Direct |
2,505
-2.08%
|
$80,160
$32.0 P/Share
|
|
Apr 12
2021
|
Frederic Vanderhaegen EVP, Americas and Europe |
SELL
Open market or private sale
|
Direct |
27,075
-5.71%
|
$839,325
$31.79 P/Share
|
|
Apr 12
2021
|
Devashish Ohri EVP, IMEA |
SELL
Open market or private sale
|
Direct |
100,160
-39.12%
|
$3,205,120
$32.37 P/Share
|
|
Apr 12
2021
|
Devashish Ohri EVP, IMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
100,160
+28.12%
|
$100,160
$1.6 P/Share
|
|
Apr 05
2021
|
Christophe Couturier EVP, AMEA |
BUY
Grant, award, or other acquisition
|
Direct |
8,267
+4.45%
|
-
|